World-renowned hearing research organisation National Acoustic Laboratories has been involved with the development of the first hearing aid since the 1940s, which is now the most widely adopted clinical hearing tool around the world. The organisation remains at the forefront of advancing hearing innovation and insights, propelling the field forward by looking beyond traditional approaches to hearing issues.
Ear Science Institute Australia is a globally recognised for-purpose organisation and centre of excellence that aligns hearing science, medicine and clinical teams to develop innovative treatments for ear and hearing disorders, and eventually find a cure for hearing loss. Ear Science covers the entire hearing treatment journey, focusing on improved quality of hearing health by prioritising the translation of its work from scientific research to the patient.
Hearing loss is one of the most common health concerns across the world, and by 2050, it’s expected nea
rly 2.5 billion people will have some degree of hearing impairment. Treating hearing loss can drastically change a person’s life by improving the ability to hear. The partnership between Ear Science and NAL represents a collaboration of expertise in research, innovation and hearing healthcare that will translate into significant life improvements for many, both locally and globally.
Both NAL and Ear Science are able to provide evidence-based insights and solutions for adoption by hearing healthcare professionals, policymakers, manufacturers and people with hearing difficulties. By integrating their extensive resources and data sets, the two organisations will work together to change the lives of people with hearing loss like never before.
“As we look towards the next era in hearing treatment, this meaningful partnership with National Acoustics Lab will bring new opportunities for knowledge sharing, leading to improved access, advanced solutions and better individual hearing care for people everywhere.”
Ear Science CEO and Adjunct Professor Sandra Bellekom
